The Form 4 filing, a report of an insider's stock trades, was filed on October 26, 2026. It covers a sale on October 23, three days earlier. The report lists Gama Paul as Procter & Gamble's health care CEO.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-23 |
| Date of Latest Transaction | 2026-10-23 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 4,331 |
| Price | $161.27 |
| Total Transaction Value | $698,460.37 |
| Insider | |
| Ticker Symbol | PG |
| Company | PROCTER & GAMBLE Co |
| Insider Name | Gama Paul |
| Insider Title | CEO- Health Care |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 46,792.88 |
| Position Size Change | 8.47% |
| Filing | |
| Filing Date | 2026-10-26 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a share sale, reported with transaction code S. Gama Paul sold 4,331 shares of Procter & Gamble (PG) in one transaction. Code S identifies the activity as a sale.
What was the average price of the transaction?
The reported average sale price was $161.27 per share. This price applies to the October 23 transaction.
How did this transaction affect the insider's holdings?
The sale reduced the reported holding by 4,331 shares, leaving 46,792.88 shares afterward. The shares sold made up 8.47% of the shares owned before the sale. A reported share balance remained after the transaction.
What's the total transaction value?
The total reported value was $698,460.37. That amount covers the 4,331 shares sold in the single transaction.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement. Filing footnotes were not provided, so any added terms or explanations in those notes remain unknown. The available details do not state a reason for the sale.
For research purposes only; not investment advice.